๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Safety and efficacy of the endoscopic modified Lothrop procedure: A systematic review and meta-analysis

โœ Scribed by Peter Anderson; Raj Sindwani


Publisher
John Wiley and Sons
Year
2009
Tongue
English
Weight
169 KB
Volume
119
Category
Article
ISSN
0023-852X

No coin nor oath required. For personal study only.

โœฆ Synopsis


Abstract

Objectives/Hypothesis:

The endoscopic modified Lothrop procedure (EMLP; also known as Draf III or frontal drillout) has recently gained popularity as a minimally invasive alternative to frontal sinus obliteration. This systematic analysis was designed to assess the safety and efficacy of the EMLP.

Study Design:

Literature review and metaโ€analysis.

Methods:

We performed a search of all English studies published from 1990 to 2008 that reported results from a minimum of five patients undergoing the EMLP. Of the 33 papers reviewed, 18 studies (evidence level IIโ€2 or IIโ€3) containing data from 612 patients met inclusion criteria.

Results:

The most common indications for EMLP were chronic frontal sinusitis (75.2%) and mucocele (21.3%). Patients had an average age of 47.9 years (range, 14โ€“89 years) and were followed for 28.5 months postoperatively. Only 20.3% of procedures were performed without imageโ€guidance. Stents were rarely used (6%). The rate of major and minor complications was <1% and 4%, respectively. No deaths were reported. A majority of patients were discharged within 24 hours. Postoperative endoscopic findings, qualitatively reported in 394 patients, demonstrated frontal sinus patency or partial stenosis in 95.9% at last followโ€up. Where specifically assessed (n = 430 patients), improvement in symptoms was achieved in 82.2% of cases, with 16% reporting no significant change, and 1.2% reporting worsening of symptoms. The overall failure rate (requiring further surgery) of EMLP was 13.9% (85/612). Of the failures, 80% underwent revision EMLP, whereas 20% elected osteoplastic frontal sinus obliteration.

Conclusions:

When performed by an experienced surgeon, EMLP is a safe and efficacious procedure that is well tolerated. Laryngoscope, 2009


๐Ÿ“œ SIMILAR VOLUMES


Safety and Efficacy of the Endoscopic Mo
โœ Peter C. Anderson; Raj H. Sindwani ๐Ÿ“‚ Article ๐Ÿ“… 2009 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 160 KB

## OBJECTIVES: The endoscopic modifi ed Lothrop procedure (EMLP; also known as Draf III or frontal drillout) has recently gained popularity as a minimally-invasive alternative to frontal sinus obliteration. This systematic analysis was designed to assess the safety and effi cacy of the EMLP. STUDY

A meta-analysis and systematic review of
โœ Nicole M. Kuderer; Alok A. Khorana; Gary H. Lyman; Charles W. Francis ๐Ÿ“‚ Article ๐Ÿ“… 2007 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 329 KB ๐Ÿ‘ 1 views

## Abstract ## BACKGROUND. Preclinical evidence suggests that anticoagulants, in particular the lowโ€molecularโ€weight heparins (LMWH), exert an antitumor effect, whereas clinical trials have reported conflicting results. The authors conducted a comprehensive, systematic review and metaโ€analysis of

Comparative efficacy of newer hypnotic d
โœ Yenal Dรผndar; Susanna Dodd; Judith Strobl; Angela Boland; Rumona Dickson; Tom Wa ๐Ÿ“‚ Article ๐Ÿ“… 2004 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 161 KB

## Abstract ## Objectives To compare the clinical effectiveness of zaleplon, zolpidem or zopiclone (Zโ€drugs) with either benzodiazepines licensed and approved for use in the UK for the shortโ€term management of insomnia (diazepam, loprazolam, lorazepam, lormetazepam, nitrazepam, temazepam) or with

Family history and the risk of breast ca
โœ Paul D.P. Pharoah; Nicholas E. Day; Stephen Duffy; Douglas F. Easton; Bruce A.J. ๐Ÿ“‚ Article ๐Ÿ“… 1997 ๐Ÿ› John Wiley and Sons ๐ŸŒ French โš– 170 KB ๐Ÿ‘ 3 views

An increased risk of breast cancer in women with a family history of breast cancer has been demonstrated by many studies using a variety of study designs. However, the extent of this risk varies according to the nature of the family history (type of relative affected, age at which relative developed